PeptidePedia The community reference

ChinaPeptides: difference between revisions

Diff·revision 21 → 22·12:06, 19 Jul 2025

Difference between revision 21 and revision 22 of ChinaPeptides. 17 lines changed; the page grew by 1,983 bytes.

Revision 21 — 19:51, 27 Jun 2025
BalanceBirdie (talk)
expand §Reception
9,996 bytes +485
Revision 22 — 12:06, 19 Jul 2025
Ref_Desk_Ron (talk)
add the incorporation year, attributed to the registry record
11,979 bytes +1,983
74The PeptidePedia tally records 902 self-reported submissions to July 2026. Recurring themes are the execution of custom-synthesis work and the presence of mass-confirmation documentation alongside the chromatographic figure, which is the pairing a custom order most needs and least often gets.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}}74The PeptidePedia tally records 902 self-reported submissions to July 2026. Recurring themes are the execution of custom-synthesis work and the presence of mass-confirmation documentation alongside the chromatographic figure, which is the pairing a custom order most needs and least often gets.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}}
7575
+76=== How this tally should be read ===
+77The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki:
+78
+79* '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
+80* '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
+81* '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}}
+82
+83== Regulatory position and legal status ==
+84The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}}
+85
+86Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}}
+87
76== References ==88== References ==
77{{reflist}}89{{reflist}}
84<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>96<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
8597
+98== Further reading ==
+99* [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain.
+100* [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki.
+101
86== See also ==102== See also ==
87* [[Certificate of analysis]]103* [[Certificate of analysis]]
91* [[Research use only]]107* [[Research use only]]
92* [[Peptide supply chain]]108* [[Peptide supply chain]]
+109* [[Blind sampling]]
93110
94{{DEFAULTSORT:ChinaPeptides}}111{{DEFAULTSORT:ChinaPeptides}}